Display options
Cite
Costa LG, Murphy SD. Interaction of the pesticide chlordimeform with adrenergic receptors in mouse brain: an in vitro study. Arch Toxicol. 1987;59(5):323-7doi: 10.1007/BF00295083.
Costa, L. G., & Murphy, S. D. (1987). Interaction of the pesticide chlordimeform with adrenergic receptors in mouse brain: an in vitro study. Archives of toxicology, 59(5), 323-7. https://doi.org/10.1007/BF00295083
Costa, L G, and Murphy, S D. "Interaction of the pesticide chlordimeform with adrenergic receptors in mouse brain: an in vitro study." Archives of toxicology vol. 59,5 (1987): 323-7. doi: https://doi.org/10.1007/BF00295083
Costa LG, Murphy SD. Interaction of the pesticide chlordimeform with adrenergic receptors in mouse brain: an in vitro study. Arch Toxicol. 1987 Feb;59(5):323-7. doi: 10.1007/BF00295083. PMID: 3034195.
Copy Download .nbib Format: NLM
Share it on
Full text links
Springer

Arch Toxicol. 1987 Feb;59(5):323-7. doi: 10.1007/BF00295083.

Interaction of the pesticide chlordimeform with adrenergic receptors in mouse brain: an in vitro study.

Archives of toxicology

L G Costa, S D Murphy

PMID: 3034195 DOI: 10.1007/BF00295083

Abstract

Chlordimeform (N'(4-chloro-o-tolyl)-N, N-dimethylformamidine; CDM) is a formamidine insecticide acaricide whose major active metabolite is its N-monomethyl analog, desmethylchlordimeform, (DCDM). While their pesticidal action in invertebrates appears to be related to activation of octopamine receptors, their mechanism of action in mammals has not been established. Because of similarities between octopamine and adrenergic receptors and suggestions of CDM and DCDM action on adrenoceptors, the in vitro interactions of CDM and DCDM with adrenoceptors were studied. In mouse brain membrane preparations CDM inhibited the binding of [3H]-clonidine to alpha 2- adrenoceptors and of [3H]-WB4101 to alpha 1-adrenoceptors with IC50 values of 18.2 and 87 microM, respectively. DCDM was a much more potent inhibitor, with IC50 values toward alpha 2-, and alpha 1-adrenoceptors of 44 nM and 1 microM, respectively. Both compounds were only weak inhibitors of the binding of [3H]-dihydroalprenolol to beta-adrenoceptors and of [3H]-quinuclidinyl benzilate to muscarinic receptors and were inactive toward benzodiazepines and gamma aminobutyric acid (GABAA) receptors. Inhibition of [3H]-clonidine binding by both compounds was competitive, as indicated by a decreased receptor affinity without changes in receptor density. Interaction of CDM and DCDM with [3H]-WB4101 binding, on the other hand, was more complex, and not of the competitive type. These results show that CDM and its metabolite DCDM can interact directly in vitro with alpha-adrenergic receptors, suggesting that these receptors could mediate some of the effects of CDM and DCDM in vivo.

References

  1. Brain Res. 1978 Jun 9;148(1):153-62 - PubMed
  2. Environ Health Perspect. 1976 Apr;14:57-69 - PubMed
  3. J Pharmacol Exp Ther. 1984 May;229(2):386-90 - PubMed
  4. Science. 1980 Apr 4;208(4439):74-6 - PubMed
  5. J Med Chem. 1982 Dec;25(12):1389-401 - PubMed
  6. Science. 1984 Oct 12;226(4671):184-7 - PubMed
  7. Nature. 1973 Mar 23;242(5395):273-4 - PubMed
  8. Life Sci. 1978 Dec 18;23(25):2509-15 - PubMed
  9. Brain Res. 1984 Jun 4;302(1):101-9 - PubMed
  10. Chem Biol Interact. 1979 Jan;24(1):35-49 - PubMed
  11. Toxicol Appl Pharmacol. 1984 May;73(3):411-5 - PubMed
  12. Mol Pharmacol. 1981 Jul;20(1):68-75 - PubMed
  13. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3805-9 - PubMed
  14. Bull Environ Contam Toxicol. 1974 Oct;12(4):446-54 - PubMed
  15. Toxicol Appl Pharmacol. 1978 May;44(2):357-65 - PubMed
  16. Proc Natl Acad Sci U S A. 1984 Jan;81(1):272-6 - PubMed
  17. Proc Natl Acad Sci U S A. 1974 May;71(5):1725-9 - PubMed
  18. Neurotoxicology. 1985 Summer;6(2):215-37 - PubMed
  19. Environ Health Perspect. 1976 Apr;14:71-82 - PubMed
  20. Toxicol Appl Pharmacol. 1988 Mar 15;92(3):402-18 - PubMed
  21. Proc Natl Acad Sci U S A. 1985 Jan;82(2):599-603 - PubMed
  22. Mol Pharmacol. 1977 May;13(3):454-73 - PubMed
  23. Neurotoxicology. 1984 Summer;5(2):91-100 - PubMed
  24. Toxicology. 1984 May 14;31(2):91-8 - PubMed
  25. Toxicol Appl Pharmacol. 1975 Aug;33(2):380-3 - PubMed
  26. J Toxicol Environ Health. 1977 Oct;3(3):565-8 - PubMed
  27. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  28. Nature. 1980 Sep 4;287(5777):60-2 - PubMed
  29. Mol Pharmacol. 1976 Jul;12(4):568-80 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources